Wei Kang, Kuan Peng, Vincent K.C. Yan, Daoud Al-Badriyeh, Shing Fung Lee, Hei Hang Edmund Yiu, . . . Esther W. Chan. (2024). Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: A cost-effectiveness analysis. Taylor & Francis Group.
Chicago Style (17th ed.) CitationWei Kang, et al. Direct Oral Anticoagulants Versus Low-molecular-weight Heparin in Patients with Cancer-associated Venous Thrombosis: A Cost-effectiveness Analysis. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationWei Kang, et al. Direct Oral Anticoagulants Versus Low-molecular-weight Heparin in Patients with Cancer-associated Venous Thrombosis: A Cost-effectiveness Analysis. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.